Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
278.32
-0.93 (-0.33%)
At close: Nov 18, 2026, 4:00 PM EST
277.00
-1.32 (-0.47%)
Pre-market: Nov 19, 2026, 8:48 AM EST
Cardinal Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Cardinal Health stock has a consensus rating of "Buy" and an average price target of $300.8. The average 1-year stock price forecast is 8.08% higher than the current stock price, while the lowest is $260 (-6.58%) and the highest is $330 (+18.57%).
Price Target: $300.8 (+8.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 11 | 11 | 11 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $275 → $320 | Buy | Maintains | $275 → $320 | +14.98% | Nov 17, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $277 → $321 | Buy | Reiterates | $277 → $321 | +15.33% | Nov 17, 2026 |
| Argus Research | Argus Research | Buy Maintains $264 → $309 | Buy | Maintains | $264 → $309 | +11.02% | Nov 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $320 | Buy | Maintains | $320 | +14.98% | Nov 10, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $260 → $286 | Hold | Maintains | $260 → $286 | +2.76% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
265.97B
from 254.25B
Increased by 4.61%
Revenue Next Year
282.25B
from 265.97B
Increased by 6.12%
EPS This Year
12.99
from 10.95
Increased by 18.62%
EPS Next Year
14.44
from 12.99
Increased by 11.21%
EPS and Forward PE are based on non-GAAP adjusted numbers.